NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1080222497

Registered date:27/05/2014

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedType 2 Diabetes Mellitus
Date of first enrollment27/05/2014
Target sample size40
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : TS-071 INN of investigational material : luseogliflozin Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral control material(s) Generic name etc : Placebo INN of investigational material : Therapeutic category code : --- Other Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary OutcomeBlood glucose(CGM)
Secondary OutcomeAdverse event

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteria- Type 2 diabetes mellitus etc.
Exclude criteria- Having non-type 2 diabetes mellitus. - Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease. etc.

Related Information

Contact

Public contact
Name
Address Clinical-trials@so.taisho.co.jp
Telephone
E-mail
Affiliation Taisho Pharmaceutical Co., Ltd
Scientific contact
Name
Address Clinical-trials@so.taisho.co.jp
Telephone
E-mail
Affiliation Taisho Pharmaceutical Co., Ltd